Team
Physiomics team members are passionate specialists with a wealth of knowledge and experience in cancer biology, quantitative pharmacology and mathematical modelling.
Dr Paul Harper
Chairman
Dr Paul Harper has over 45 years’ experience in life sciences, drug development and medical devices.
Learn more
Dr Jim Millen
Chief Executive Officer
Dr Jim Millen brings over 15 years experience in pharmaceuticals and biotechnology.
Learn more
Dr Christophe Chassagnole
Chief Operating Officer
Dr Christophe Chassagnole has led systems biology and bio-computing projects for over 15 years.
Learn more
Anthony Clayden
Head of Finance
Anthony Clayden brings over 22 years experience guiding high growth potential businesses.
Learn more
Hayley Close
Head of Business Development
Hayley Close joins Physiomics with 5 years business development experience.
Learn more
Dr Frances Brightman
Project Leader
Dr Frances Brightman is a computational biology specialist with over 14 years experience.
Learn more
Dr Fernando Ortega
Senior PK/PD Modeller
Dr Fernando Ortega brings over a decade’s experience in developing mechanistic models.
Learn more
Dr Claire Villette
Senior Biomodelling Scientist
Dr Claire Villette is a biomedical computational scientist with over 6 years experience.
Learn more
Nathalie Dupuy
Biosimulation Scientist
Nathalie Dupuy is a biomedical computational scientist with experience in data science, machine learning and computational neuroscience.
Learn more
Charmaine Fraser
Administration Manager
Charmaine Fraser brings with her over 10 years of Administrative and Managerial experience.
Learn more
Dr Hitesh Mistry
Principal Consultant, Clinical Modelling
Dr Hitesh Mistry, is a modelling and simulation specialist within the pharmaceutical industry.
Learn more
Dr David Orrell
Principal Consultant, Modelling & Simulation, Scientific Advisor
Dr David Orrell is an applied mathematician with a PhD from Oxford University.
Learn more
Scientific Advisors
Dr Robert Jackson
Consultant and Scientific Advisory Board Member
Dr Robert Jackson obtained his PhD in biochemical pharmacology from the Institute of Cancer Research and has led many senior appointments in multinational pharmaceuticals.
Learn more
Professor Mark Middleton
Consultant and Scientific Advisory Board Member
Mark Middleton is Professor of Experimental Cancer Medicine at Dept. of Oncology and consultant Medical Oncologist at Oxford Cancer and Haematology Centre.
Learn more
Professor David Fell
Co-Founder and Scientific Advisory Board Member
David Fell is Professor of Biochemistry & Assistant Dean, School of Life Sciences at Oxford Brookes University, specialising in systems biology and metabolic modelling.
Learn more